| SZ CAT No: | CL-LROD-15 |
| CAS No: | NA |
| Mol.F: | C54H69N11O11S2 |
| Mol.Wt.: | 1112.3 |
| Chemical Name: | (4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide 1-oxide |
| SMILES: | Smiles Not Available |
| Inventory Status: | Custom synthesis |
This impurity is related to Lanreotide Mono Sulfoxide Impurity is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Lanreotide Mono Sulfoxide Impurity is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(4R,7S,10S,13R,16S,19R)-13-((1H-Indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide 1-oxideCountry of Origin: India Product Category: PeptidesAPI NAME: Lanreotide Molecular Formula: C54H69N11O11S2
Molecular Weight: 1112.3
Storage: Store in a cool, dry place.
Cat. No: CL-LROD-01
CAS No: 150155-56-9
Mol. F: C54H68N10O11S2
Mol. Wt: 1097.3
Inv. Status: Custom Synthesis
Cat. No: CL-LROD-02
CAS No: 109605-17-6
Mol. F: C56H71N11O11S2
Mol. Wt: 1138.4
Inv. Status: Custom Synthesis
Cat. No: CL-LROD-03
CAS No: NA
Mol. F: C50H62N10O8S2
Mol. Wt: 995.2
Inv. Status: Custom Synthesis
Cat. No: CL-LROD-04
CAS No: NA
Mol. F: C50H61N9O9S2
Mol. Wt: 996.2
Inv. Status: Custom Synthesis
Cat. No: CL-LROD-05
CAS No: 205234-49-7
Mol. F: C54H69N11O10S2
Mol. Wt: 1096.3
Inv. Status: Custom Synthesis
Cat. No: CL-LROD-06
CAS No: NA
Mol. F: C54H69N11O10S2
Mol. Wt: 1096.32
Inv. Status: Custom Synthesis
Cat. No: CL-LROD-07
CAS No: NA
Mol. F: C41H58N10O9S2
Mol. Wt: 899.1
Inv. Status: Custom Synthesis
-Acid-Lanreotide.jpg)
Cat. No: CL-LROD-08
CAS No: NA
Mol. F: C50H61N9O9S2
Mol. Wt: 996.2
Inv. Status: Custom Synthesis
-Lanreotide.jpg)
Cat. No: CL-LROD-09
CAS No: NA
Mol. F: C50H62N10O8S2
Mol. Wt: 995.2
Inv. Status: Custom Synthesis
Cat. No: CL-LROD-10
CAS No: NA
Mol. F: C54H69N11O10S2
Mol. Wt: 1096.3
Inv. Status: Custom Synthesis
Cat. No: CL-LROD-11
CAS No: 127984-74-1
Mol. F: C54H69N11O10S2 : X(C2H4O2)
Mol. Wt: 1096.3 : X(60.1)
Inv. Status: Custom Synthesis
Cat. No: CL-LROD-12
CAS No: NA
Mol. F: C108H138N22O20S4
Mol. Wt: 2192.7
Inv. Status: Custom Synthesis
Cat. No: CL-LROD-13
CAS No: NA
Mol. F: C54H69N11O14S2
Mol. Wt: 1160.3
Inv. Status: Custom Synthesis
Cat. No: CL-LROD-14
CAS No: NA
Mol. F: C54H69N11O12S2
Mol. Wt: 1128.3
Inv. Status: Custom Synthesis
Cat. No: CL-LROD-16
CAS No: NA
Mol. F: C108H138N22O20S4
Mol. Wt: 2192.7
Inv. Status: Custom Synthesis
Cat. No: CL-LROD-17
CAS No: NA
Mol. F: C54H69N11O10S3
Mol. Wt: 1114.4
Inv. Status: Custom Synthesis
 Lanreotide.jpg)
Cat. No: CL-LROD-18
CAS No: 113294-82-9
Mol. F: C54H71N11O10S2
Mol. Wt: 1098.3
Inv. Status: Custom Synthesis
Cat. No: CL-LROD-19
CAS No: 1219612-61-9
Mol. F: C54H69N11O10S2
Mol. Wt: 1096.3
Inv. Status: Custom Synthesis
5 Lanreotide.jpg)
Cat. No: CL-LROD-20
CAS No: 1353092-24-6
Mol. F: C56H71N11O11S2
Mol. Wt: 1138.4
Inv. Status: Custom Synthesis
Cat. No: CL-LROD-21
CAS No: 205234-53-3
Mol. F: C54H69N11O10S2
Mol. Wt: 1096.3
Inv. Status: Custom Synthesis
Cat. No: CL-LROD-22
CAS No: NA
Mol. F: C45H60N10O8S2
Mol. Wt: 933.2
Inv. Status: Custom Synthesis
Cat. No: CL-LROD-24
CAS No: NA
Mol. F: C54H61D8N11O10S2
Mol. Wt: 1104.4
Inv. Status: Custom Synthesis
| CAT No: | CL-LROD-15 |
| CAS No: | NA |
| Mol.F: | C54H69N11O11S2 |
| Mol.Wt: | 1112.3 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: